Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|June 28, 2023

WCG Partners with Mint Medical

Partnership will support imaging in oncology clinical trials.

WCG and Mint Medical have partnered to leverage Mint Medical mint Lesion™ radiology platform for oncology trials. WCG will combine its suite of clinical trial management solutions: operational processes, quality systems, imaging solutions, technology, and reviewer network with Mint Lesion's™ verified, read-ready platform, structured reporting, and site-specific workflows.

The Mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. It also offers more than 20 standardized and configurable response criteria templates out of the box.

"The combination of WCG and Mint Medical offers a powerful solution to the market. WCG's teams are experts in study management and have a proven record of managing international clinical trials across all therapeutic areas and indications, including oncology," said Terri Moench, president, WCG Clinical Research Solutions. "Our ISO-certified processes ensure the processing of participant images received from sites are meticulously planned, implemented, and monitored for success. Combine that with mint Lesion™, a technology built to keep pace with changing requirements and the demand for new response criteria, and you have a solution that is unmatched in the industry."

Reference: WCG Announces Partnership with Mint Medical to Support Imaging in Oncology Clinical Trials. PRINCETON, NJ, June 28, 2023 /PRNewswire.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.